Avinash G. Dinmohamed

Author

Netherlands Comprehensive Cancer Organisation ORCID

Also Known As

A G Dinmohamed, A. Dinmohamed, A. G. Dinmohamed, A.G. Dinmohamed, Avinash Dinmohamed, Avinash G Dinmohamed, Avinash G. Dinmohamed, Avinash G Dinmohamed

135

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Netherlands Comprehensive Cancer Organisation Erasmus MC Erasmus MC Cancer Institute Amsterdam University Medical Centers Radboud University Medical Center

About

Avinash G. Dinmohamed is an author at Netherlands Comprehensive Cancer Organisation specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	533
2	Public Health	5	5	198
3	Epidemiology	5	5	198
4	Health Sciences	4	4	168
5	Geriatrics	1	1	13

Avinash G. Dinmohamed

Publications

994

Citations

H-Index

Page 1

	Year	Citations
The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands Avinash G. Dinmohamed, Matteo Cellamare, Otto Visser, Journal of Hematology & Oncology	2020	145
Two <i>Plasmodium</i> 6‐Cys family‐related proteins have distinct and critical roles in liver‐stage development Takeshi Annoura, Ben C. L. van Schaijk, Ivo Ploemen, The FASEB Journal	2014	89
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012 Avinash G. Dinmohamed, Otto Visser, Yvette van Norden, Leukemia Hematological MalignancyPopulation-based StudyTrial ParticipationMedicineHematology	2015	77
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population Isabelle A. van Zeventer, Aniek O. de Graaf, Jonas B. Salzbrunn, Cancer Cell Evolutionary LandscapeLaboratory HematologyMolecular EcologyMedicineGenetics	2023	69
Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival Avinash G. Dinmohamed, Anikó Szabó, Marianne van der Mark, Leukemia Hematological MalignancyOncologyTrial ParticipationMixed-phenotype Acute LeukemiaAdult Patients	2015	68
Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010 Avinash G. Dinmohamed, Otto Visser, Yvette van Norden, European Journal of Cancer Hematological MalignancyPopulation-based StudyBone Marrow FailureMyelodysplastic SyndromesInitial Treatment	2014	64
Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality Ardine Reedijk, Kim Klein, J.W.W. Coebergh, Leukemia Hematological MalignancyYoung AdolescentsPediatric EpidemiologyMedicineAcute Myeloid Leukemia	2018	62
Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet—a population-based study Avinash G. Dinmohamed, Otto Visser Stem Cell Investigation Mixed-phenotype Acute LeukemiaEpidemiology Of CancerGenetic EpidemiologyPopulation Health SciencesRarecarenet—a Population-based Study	2019	46
The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands Avinash G. Dinmohamed, Yvette van Norden, Otto Visser, Leukemia Research Hematological MalignancyHealth PolicyMyelodysplastic SyndromesMixed-phenotype Acute LeukemiaClinical Epidemiology	2014	43
Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands Avinash G. Dinmohamed, Eduardus F. M. Posthuma, Otto Visser, Blood	2018	34

Page 1